This morning Solid Biosciences provided an update to the market which included new patient data from their IGNITE DMD clinical program. Please find below the press release and corresponding letter they drafted to the Duchenne community.

Community Letter: https://www.solidbio.com/about/media/news/letter-to-the-duchenne-community-data-and-ignite-dmd-clinical-trial-update-1

Press Release: https://www.solidbio.com/about/media/press-releases/solid-biosciences-reports-fourth-quarter-and-full-year-2019-financial-results-and-provides-business-update